ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli +17 more
wiley +1 more source
Left coronary cusp ablation for elimination of left ventricular summit premature ventricular complex
Journal of Arrhythmia, 2023 Wipat Phanthawimol +2 more
doaj +1 more source
Wide Complex Tachycardias—The Differential Diagnosis Remains Wide and Complex [PDF]
, 2007 John M. Miller, Anil V. Yadav
openalex +1 more source
Answer: Never skip a beat: pacing-induced polymorphic ventricular tachycardia following inferior myocardial infarction [PDF]
, 2021 Lung En Teng, Sean Tan, Roshan Prakash
openalex +1 more source
How to read the equine electrocardiogram? : tips and tricks [PDF]
, 2011 C
van Loon, Gunther
core +1 more source
Closed chest modification of atrioventricular conduction system in man for treatment of refractory supraventricular tachycardia. [PDF]
, 1983 G Critelli +4 more
openalex +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
216-31: Clinical, Electrocardiographic, and Electrophysiologic Characteristics of the Patients with Focal Atrial Tachycardia [PDF]
, 2016 Peyman Tabatabaie +4 more
openalex +1 more source
EASI Monitoring: An Alternative to Conventional Electrocardiography in the Recording of Ventricular Tachycardia [PDF]
, 2023 Mauro Buelga Suárez +8 more
openalex +1 more source
ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh +18 more
wiley +1 more source